Poniard Pharmaceuticals Inc
Poniard Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of cancer therapeutics. Its lead platform product candidate includes Picoplatin, a platinum-based cancer therapy to treat multiple cancer indications, including small cell lung, colorectal, prostate, and ovarian cancers. The company has conducted a pivotal Phase III SPEAR trial of Picoplat… Read more
Poniard Pharmaceuticals Inc (PARD) - Total Liabilities
Latest total liabilities as of September 2011: $4.62 Million USD
Based on the latest financial reports, Poniard Pharmaceuticals Inc (PARD) has total liabilities worth $4.62 Million USD as of September 2011.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Poniard Pharmaceuticals Inc - Total Liabilities Trend (1988–2010)
This chart illustrates how Poniard Pharmaceuticals Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Poniard Pharmaceuticals Inc Competitors by Total Liabilities
The table below lists competitors of Poniard Pharmaceuticals Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Mansfelder Metals Ltd
PINK:MNSF
|
USA | $30.86 Million |
|
Merriman Holdings Inc
PINK:MERR
|
USA | $6.93 Million |
|
Colombia Energy Resources Inc
PINK:CERX
|
USA | $5.82 Million |
|
Circuit Research Labs Inc
PINK:CRLI
|
USA | $6.50 Million |
|
Commerce Group Corp
PINK:CGCO
|
USA | $37.92 Million |
|
TFN Football Network
PINK:TFBN
|
USA | $237.83K |
|
EnerNorth Industries Inc
OTCGREY:ENYNF
|
USA | $11.98 Million |
Liability Composition Analysis (1988–2010)
This chart breaks down Poniard Pharmaceuticals Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.76 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.48 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.60 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Poniard Pharmaceuticals Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Poniard Pharmaceuticals Inc (1988–2010)
The table below shows the annual total liabilities of Poniard Pharmaceuticals Inc from 1988 to 2010.
| Year | Total Liabilities | Change |
|---|---|---|
| 2010-12-31 | $3.19 Million | -88.92% |
| 2009-12-31 | $28.80 Million | -21.28% |
| 2008-12-31 | $36.59 Million | +128.16% |
| 2007-12-31 | $16.04 Million | -27.69% |
| 2006-12-31 | $22.18 Million | +219.49% |
| 2005-12-31 | $6.94 Million | +5.04% |
| 2004-12-31 | $6.61 Million | +6.56% |
| 2003-12-31 | $6.20 Million | -26.33% |
| 2002-12-31 | $8.42 Million | -9.62% |
| 2001-12-31 | $9.31 Million | +320.83% |
| 2000-12-31 | $2.21 Million | -26.23% |
| 1999-12-31 | $3.00 Million | -11.76% |
| 1998-12-31 | $3.40 Million | +17.24% |
| 1997-12-31 | $2.90 Million | -14.71% |
| 1996-12-31 | $3.40 Million | -5.56% |
| 1995-12-31 | $3.60 Million | -14.29% |
| 1994-12-31 | $4.20 Million | +40.00% |
| 1993-12-31 | $3.00 Million | -25.00% |
| 1992-12-31 | $4.00 Million | -66.94% |
| 1991-12-31 | $12.10 Million | -8.33% |
| 1990-12-31 | $13.20 Million | -65.17% |
| 1989-12-31 | $37.90 Million | +340.70% |
| 1988-12-31 | $8.60 Million | -- |